As an adaptor, WDR4 binds DDX20 and represses the transcription factor Egr1, thereby inhibiting the transcriptional expression of ARRB2 and ultimately promoting the progression of bladder cancer. This evidence concerns the gene WDR4 and urinary bladder cancer.